期刊
ANALYTICA CHIMICA ACTA
卷 493, 期 1, 页码 69-81出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0003-2670(03)00864-X
关键词
doxorubicin; anthracycline; PARAFAC; human plasma; excitation-emission fluorescence; drugs
Direct determination of doxorubicin (DXR), a cytotoxic anthracycline antibiotic, in human plasma was accomplished based on excitation-emission matrix (EEM) fluorescence measurements and multi-way chemometric methods based on parallel factor analysis (PARAFAC) and N-PLS. Several different procedures, such as residual analysis, core consistency diagnostic (CONCORDIA) and split-half analysis were employed to determine the correct number of factors in PARAFAC. These procedures converged to a choice of two factors, attributed to DXR and to the sum of two fluorescence species present in the plasma. Sample PARAFAC loadings were employed to build a regression model against concentration, resulting in a RMSECV of 0.060 mug ml(-1). N-PLS using two factors produced a RMSECV of 0.045 mug ml(-1). Figures of merit (FOM), such as sensitivity (SEN), selectivity (SEL) and limit of detection (LD) were determined for both PARAFAC and N-PLS. (C) 2003 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据